Technical Analysis for ABLX - Ablynx NV
|Grade||Last Price||% Change||Price Change|
ABLX closed down 1.7 percent on Friday, January 19, 2018, on 68 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical ABLX trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 19||Calm After Storm||Range Contraction||0.00%|
|Jan 19||Wide Bands||Range Expansion||0.00%|
|Jan 19||Overbought Stochastic||Strength||0.00%|
|Jan 18||Calm After Storm||Range Contraction||-1.70%|
|Jan 18||Wide Bands||Range Expansion||-1.70%|
|Jan 18||Gapped Up||Strength||-1.70%|
|Jan 18||Overbought Stochastic||Strength||-1.70%|
|Jan 17||1,2,3 Pullback Bullish||Bullish Swing Setup||0.48%|
|Jan 17||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.48%|
|Jan 17||Calm After Storm||Range Contraction||0.48%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
- Earnings date: ???
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. Ablynx has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ABLX news...
|52 Week High||45.77|
|52 Week Low||17.75|
|200-Day Moving Average||0.0|
|50-Day Moving Average||26.5164|
|20-Day Moving Average||32.2435|
|10-Day Moving Average||40.192|
|Average True Range||1.8273|
|Chandelier Exit (Long, 3 ATRs )||40.2881|
|Chandelier Exit (Short, 3 ATRs )||28.8119|
|Upper Bollinger Band||49.6418|
|Lower Bollinger Band||14.8452|
|Percent B (%b)||0.77|
|MACD Signal Line||4.1658|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||43.33|
|Resistance 3 (R3)||43.39||42.88||43.04|
|Resistance 2 (R2)||42.88||42.45||42.85||42.95|
|Resistance 1 (R1)||42.26||42.18||42.01||42.20||42.85|
|Support 1 (S1)||41.13||41.32||40.88||41.07||40.41|
|Support 2 (S2)||40.62||41.05||40.59||40.31|
|Support 3 (S3)||40.00||40.62||40.22|
|Support 4 (S4)||39.94|